Structural requirements for bone sialoprotein binding and modulation of matrix metalloproteinase-2

Biochemistry

Volumn 47, Issue 38, 2008, Pages 10162-10170

  Jain, Alka ^a   Karadag, Abdullah ^a,b   Fisher, Larry W ^a   Fedarko, Neal S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINATION; AMINES; AMINO ACIDS; BINDING SITES; BONE; FOOD ADDITIVES; MATRIX ALGEBRA; MODULATION; ORGANIC ACIDS; ULSI CIRCUITS;

ACTIVE SITES; ACTIVITY ASSAYS; AMINO ACID DOMAIN; BINDING ASSAYS; BONE SIALOPROTEIN; ENZYMATIC ACTIVITIES; GELATINASE; HEMOPEXIN; MATRIX METALLOPROTEINASE-2; PROPEPTIDE; PROTEASE ACTIVITIES; STRUCTURAL DOMAINS; STRUCTURAL REQUIREMENTS; TISSUE INHIBITORS;

ENZYME ACTIVITY;

BONE SIALOPROTEIN; GELATINASE A; HEMOPEXIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

AMINO TERMINAL SEQUENCE; ARTICLE; BAY REGION BINDING SITE; BINDING AFFINITY; BINDING ASSAY; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; EXON; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; STRUCTURAL PROTEOMICS;

AMINO ACID SEQUENCE; ENZYME ACTIVATION; ENZYME PRECURSORS; HUMANS; MATRIX METALLOPROTEINASE 2; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; SIALOGLYCOPROTEINS; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 52249098010     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi801068p     Document Type: Article

References (30)

1. Fisher, L. W., Torchia, D. A., Fohr, B., Young, M. F., and Fedarko, N. S. (2001) The solution structures of two SIBLING proteins, bone sialoprotein and osteopontin, by NMR. Biochem. Bophys. Res. Commun. 280, 460-465.
2. Christensen, B., Kazanecki, C. C., Petersen, T. E., Rittling, S. R., Denhardt, D. T., and Sorensen, E. S. (2007) Cell type-specific posttranslational modifications of mouse osteopontin are associated with different adhesive properties. J. Biol. Chem. 282, 19463-19472.
3. Ogburcke, K. U., and Fisher, L. W. (2007) SIBLING expression patterns in duct epithelia reflect the degree of metabolic activity. J. Histochem. Cytochem. 55, 403-409.
4. Bellahcene, A., Castronovo, V., Ogbureke, K. U., Fisher, L. W., and Fedarko, N. S. (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGS); multifunctional proteins in cancer. Nat. Rev. Cancer 8, 212-226.
5. El-Tanani, M. K., Campbell, F. C., Kurisetty, V., Jin, D., McCann, M., and Rudland, P. S. (2006) The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev. 17, 463-474.
6. Fisher, L. W., Jain, A., Tayback, M., and Fedarko, N. S. (2004) Small Integrin Binding Ligand N-linked Glycoprotein (SIBLING) gene family expression in different cancers. Clin. Can. Res. 10, 8501-8511.
7. Weber, G. F. (2001) The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim. Biophys. Acta 1552, 61-85.
8. Fedarko, N. S., Fohr, B., Robey, P. G., Young, M. F., and Fisher, L. W. (2000) Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J. Biol. Chem. 275, 16666-16672.
9. Karadag, A., Ogbureke, K. U., Fedarko, N. S., and Fisher, L. W. (2004) Bone sialoprotein, matrix metalloproteinase 2, and alpha(v) beta3 integrin in osteotropic cancer cell invasion. J. Natl. Cancer Inst. 96, 956-965.
10. Jain, A., Karadag, A., Fohr, B., Fisher, L. W., and Fedarko, N. S. (2002) Three SIBLINGS (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack. J. Biol. Chem. 277, 13700-13708.
11. Fedarko, N. S., Jain, A., Karadag, A., and Fisher, L. W. (2004) Three small integrin binding ligand N-linked glycoproteins (SIBLINGS) bind and activate specific matrix metalloproteinases. FASEB J. 18, 734-736.
12. Jain, A., Fisher, L. W., and Fedarko, N. S. (2008) Bone sialoprotein binding to matrix metalloproteinase-2 alters enzyme inhibition kinetics. Biochemistry 47, 5986-5995.
13. Fedarko, N. S., Fohr, B., Gehron Robey, P., Young, M. F., and Fisher, L. W. (2000) Factor H binding to bone sialoprotein and osteopontin enables molecular cloaking of tumor cells from complement-mediated attack. J. Biol. Chem. 275, 16666-16672.
14. Mintz, K. P., Grzesik, W. J., Midura, R. J., Robey, P. G., Termine, J. D., and Fisher, L. W. (1993) Purification and fragmentation of nondenatured bone sialoprotein: evidence for a cryptic, RGD-resistant cell attachment domain. J. Bone Miner. Res. 8, 985-995.
15. Springman, E. B., Angleton, E. L., Birkedal-Hansen, H., and Van Wart, H. E. (1990) Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc. Natl. Acad. Sci. U.S.A. 87, 364-368.
16. Midura, R. J., McQuillan, D. J., Benliam. K. J., Fisher, L. W., and Hascall, V. C. (1990) A rat osteogenic cell line (UMR 106-01) synthesizes a highly sulfated form of bone sialoprotein. J. Biol. Chem. 265, 5285-5291.
17. Murphy, G., and Knauper, V. (1997) Relating matrix metallopro-teinase structure to function: why the "hemopexin" domain? Matrix Biol. 15, 511-518.
18. Verma, R. P., and Hansch, C. (2007) Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg. Med. Chem. 15, 2223-2268.
19. Van Wart, H. E., and Birkedal-Hansen, H. (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U.S.A. 87, 5578-5582.
20. Vallee, B. L., and Auld, D. S. (1990) Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry 29, 5647-5659.
21. 2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components. J. Biol. Chem. 272, 7473-7481.
22. Overall, C. M. (2002) Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol Biotechnol. 22, 51-86.
23. Tarn, E. M., Moore, T. R., Butler, G. S., and Overall, C. M. (2004) Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MTl-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities. J. Biol. Chem. 279, 43336-43344.
24. Corcoran, M. L., Hewitt, R. E., Kleiner, D. E., Jr., and Stetler-Stevenson, W. G. (1996) MMP-2: expression, activation and inhibition. Enzyme Protein 49, 7-19.
25. Stubbs, J. T., III, Mintz, K. P., Eanes, E. D., Torchia, D. A., and Fisher, L. W. (1997) Characterization of native and recombinant bone sialoprotein: delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain. J. Bone Miner. Res. 12, 1210-1222.
26. Fisher, L. W., Torchia, D. A., Fohr, B., Young, M. F., and Fedarko, N. S. (2001) Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem. Biophys. Res. Commun. 280, 460-465.
27. Tompa, P., Szasz, C., and Buday, L. (2005) Structural disorder throws new light on moonlighting. Trends Biochem. Sci. 30, 484-489.
28. Fujisawa, R., and Kuboki, Y. (1992) Affinity of bone sialoprotein and several other bone and dentin acidic proteins to collagen fibrils. Calcif. Tissue Int. 51, 438-442.
29. Fisher, L. W., McBride, O. W., Termine, J. D., and Young, M. F. (1990) Human bone sialoprotein. Deduced protein sequence and chromosomal localization. J. Biol. Chem. 265, 2347-2351.
30. Olson, M. W., Gervasi, D. C., Mobashery, S., and Fridman, R. (1997) Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol Chem. 272, 29975-29983.